Clinical Oncology Next Generation Sequencing Market to Reach USD 1.18 Billion by 2030 | Straits Research
The global Clinical Oncology Next Generation Sequencing (NGS) Market has witnessed substantial growth in recent years and is expected to continue this upward trajectory. According to Straits Research, the Clinical Oncology NGS Market was valued at USD 339.10 Million in 2021 and is projected to reach USD 1.18 Billion by 2030, growing at a CAGR of 14.95% during the forecast period (2022–203. This surge is attributed to the increasing prevalence of cancer, technological advancements in sequencing methods, and the growing demand for precision medicine in oncology.
Download Free Report with Complimentary Analyst Consultation :
Commentaire
Publier
Devenez cette étoile ★ (bideew), faites de nouvelles rencontres sur la plus grande communauté en Afrique et partagez vos meilleurs moments avec vos proches 
